You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Graft-Versus-Host Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients at Risk for Chronic Graft-Versus-Host Disease

Not yet recruiting
  • cGVHD
  • Non-Interventional
  • (no location specified)
Jun 16, 2023

Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Atlanta, Georgia
    Northside Hospital
Sep 21, 2023

Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • Allogeneic Stem Cell Transplant
  • App
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))

Recruiting
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cells (MSCs)
  • Shapingba, Chongqing, China
    Xinqiao Hospital
Nov 24, 2023

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Chronic GVHD Trial in United States (drug, procedure, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • Tampa, Florida
    • +4 more
    Aug 10, 2023

    Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Duarte, California
      City of Hope Site Number : 8400001
    Nov 23, 2023

    Chronic Graft Vs. Host Disease Trial (INCA34176)

    Available
    • Chronic Graft Vs. Host Disease
    • (no location specified)
    Sep 14, 2022

    Chronic GVHD Trial in United States (Ofatumumab)

    Completed
    Has Results
    • Chronic Graft Versus Host Disease
    • Phoenix, Arizona
    • +3 more
    Sep 30, 2022

    Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

    Active, not recruiting
    • Chronic Graft vs Host Disease
    • Chronic Graft-Versus-Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 29, 2022

    Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Steroid Refractory Graft Versus Host Disease
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Chronic GVHD Trial in Bethesda, Saint Louis (Ibrutinib)

    Recruiting
    • Chronic GVHD
    • Bethesda, Maryland
    • +1 more
    Jan 26, 2023

    Chronic GVHD Trial in Duarte (biological, procedure, other)

    Active, not recruiting
    • Chronic Graft Versus Host Disease
    • Aldesleukin
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Chronic GVHD Trial (Belumosudil)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • (no location specified)
    Jan 5, 2023

    Clinical and Biological Factors Determining Outcomes in Chronic

    Recruiting
    • Chronic Graft vs Host Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

      Active, not recruiting
      • Chronic Graft-versus-host-disease
      • Salt Lake City, Utah
        Huntsman Cancer Institute at University of Utah
      Jan 30, 2023

      Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease, Solid Organ Transplant Trial in Cincinnati (Ruxolitinib)

      Recruiting
      • Acute-graft-versus-host Disease
      • +2 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Mar 31, 2022

      GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

      Terminated
      Has Results
      • Graft Versus Host Disease
      • +2 more
      • Ruxolitinib 1.5% cream
      • vehicle cream
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 21, 2022

      Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention

      Recruiting
      • Graft Vs Host Disease
      • +2 more
      • Exercise
      • Attention control
      • Boston, Massachusetts
      • +1 more
      Nov 28, 2022

      Chronic Graft-versus-host-disease Trial in Monterrey (Low-dose ibrutinib)

      Recruiting
      • Chronic Graft-versus-host-disease
      • Low-dose ibrutinib
      • Monterrey, Nuevo Leon, Mexico
        Hospital Universitario Dr. José Eleuterio González
      Apr 21, 2022

      Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

      Recruiting
      • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
      • topical ruxolitinib 1.5% cream
      • Topical vehicle/moisturizer cream
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 20, 2022

      Ocular Surface Disease in Chronic Graft-Versus-Host Disease

      Recruiting
      • Dry Eye
      • GVHD
      • Cross-sectional study
      • Singapore, Singapore
        Cynthia Boo
      Mar 22, 2022

      Dendritic Cells in Acute or Chronic Skin Graft Versus Host

      Recruiting
      • Acute Graft-versus-host Disease
      • +3 more
      • Skin punch biopsy
      • Peripheral blood draw
      • Saint Louis, Missouri
        Washington University School of Medicine
      May 31, 2022

      Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • +2 more
      • Biopsy
      • +11 more
      • Duarte, California
        City of Hope Medical Center
      Aug 7, 2023

      cGVHD Trial in Guanzhou (Belimumab (Benlysta))

      Withdrawn
      • cGVHD
      • Belimumab (Benlysta)
      • Guanzhou, China
        Department of Hematology, Nanfang Hospital, Southern Medical Uni
      Jan 16, 2023